Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Whyte, Claire S.; Morrow, Gael B.; Mitchell, Joanne L.; Chowdary, Pratima; Mutch, Nicola J.

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Files

Whyte_etal_jth_Fibrinolytic_abnormalities_VOR.pdf (802.1 KB)

Date

2020-07

Authors

Citation

Whyte, C S, Morrow, G B, Mitchell, J L, Chowdary, P & Mutch, N J 2020, 'Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19', Journal of Thrombosis and Haemostasis, vol. 18, no. 7, pp. 1548-1555. https://doi.org/10.1111/jth.14872